(+)-schisandrin B multiple interactions ISO Sh3bp5 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SH3BP5 mRNA] CTD PMID:31150632 1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of SH3BP5 mRNA CTD PMID:28960355 1,3,5-trinitro-1,3,5-triazinane decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 cyclonite results in decreased expression of SH3BP5 mRNA CTD PMID:25559034 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SH3BP5 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of SH3BP5 mRNA CTD PMID:29097150 17beta-estradiol increases expression ISO SH3BP5 (Homo sapiens) 6480464 Estradiol results in increased expression of SH3BP5 mRNA CTD PMID:20106945 17beta-estradiol decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Estradiol results in decreased expression of SH3BP5 mRNA CTD PMID:32145629 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SH3BP5 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SH3BP5 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of SH3BP5 mRNA CTD PMID:22298810 and PMID:34747641 2,4-dinitrotoluene affects expression ISO Sh3bp5 (Rattus norvegicus) 6480464 2 and 4-dinitrotoluene affects the expression of SH3BP5 mRNA CTD PMID:21346803 2-palmitoylglycerol increases expression ISO SH3BP5 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of SH3BP5 mRNA CTD PMID:37199045 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 3 more ... CTD PMID:23196670 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 3 more ... CTD PMID:32119087 3,4-methylenedioxymethamphetamine increases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SH3BP5 mRNA CTD PMID:30071829 3-chloropropane-1,2-diol decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 alpha-Chlorohydrin analog results in decreased expression of SH3BP5 protein and alpha-Chlorohydrin results in decreased expression of SH3BP5 protein CTD PMID:26597043 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO SH3BP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SH3BP5 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of SH3BP5 mRNA CTD PMID:18648102 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of SH3BP5 mRNA CTD PMID:28973697 8-Br-cAMP increases expression ISO SH3BP5 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SH3BP5 mRNA CTD PMID:22079614 acrylamide increases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Acrylamide results in increased expression of SH3BP5 mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO SH3BP5 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of SH3BP5 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO SH3BP5 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of SH3BP5 mRNA CTD PMID:32234424 all-trans-retinoic acid increases expression ISO SH3BP5 (Homo sapiens) 6480464 Tretinoin results in increased expression of SH3BP5 mRNA CTD PMID:21934132 and PMID:23830798 ammonium chloride affects expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of SH3BP5 mRNA CTD PMID:16483693 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of SH3BP5 mRNA CTD PMID:23650126 arotinoid acid multiple interactions ISO SH3BP5 (Homo sapiens) 6480464 [4-(2-(5 more ... CTD PMID:34480604 Bardoxolone methyl affects expression ISO SH3BP5 (Homo sapiens) 6480464 bardoxolone methyl affects the expression of SH3BP5 mRNA CTD PMID:34480604 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of SH3BP5 mRNA CTD PMID:19770486 and PMID:21569818 benzo[a]pyrene increases expression ISO SH3BP5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of SH3BP5 mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation ISO SH3BP5 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of SH3BP5 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO SH3BP5 (Homo sapiens) 6480464 7 more ... CTD PMID:20018196 benzo[e]pyrene decreases methylation ISO SH3BP5 (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of SH3BP5 intron CTD PMID:30157460 bisphenol A affects expression ISO Sh3bp5 (Rattus norvegicus) 6480464 bisphenol A affects the expression of SH3BP5 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SH3BP5 mRNA CTD PMID:34585602 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SH3BP5 mRNA CTD PMID:33221593 bisphenol A decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of SH3BP5 mRNA CTD PMID:32145629 bisphenol A increases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of SH3BP5 mRNA CTD PMID:30816183 and PMID:34947998 bisphenol F multiple interactions ISO SH3BP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SH3BP5 mRNA CTD PMID:28628672 buspirone increases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Buspirone results in increased expression of SH3BP5 mRNA CTD PMID:24136188 buta-1,3-diene decreases expression EXP 6480464 1 and 3-butadiene results in decreased expression of SH3BP5 mRNA CTD PMID:29038090 butanal decreases expression ISO SH3BP5 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of SH3BP5 mRNA CTD PMID:26079696 cadmium dichloride increases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Cadmium Chloride results in increased expression of SH3BP5 mRNA CTD PMID:33453195 capsaicin decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Capsaicin results in decreased expression of SH3BP5 mRNA CTD PMID:16278290 carbamazepine affects expression ISO SH3BP5 (Homo sapiens) 6480464 Carbamazepine affects the expression of SH3BP5 mRNA CTD PMID:25979313 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 CHIR 99021 multiple interactions ISO SH3BP5 (Homo sapiens) 6480464 [4-(2-(5 more ... CTD PMID:34480604 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of SH3BP5 mRNA CTD PMID:23125180 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of SH3BP5 mRNA CTD PMID:21151649 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SH3BP5 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SH3BP5 mRNA] CTD PMID:17585979 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of SH3BP5 mRNA CTD PMID:23811191 cobalt dichloride increases expression ISO SH3BP5 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of SH3BP5 mRNA CTD PMID:19376846 cobalt dichloride decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 cobaltous chloride results in decreased expression of SH3BP5 mRNA CTD PMID:24386269 cortisol multiple interactions ISO SH3BP5 (Homo sapiens) 6480464 [4-(2-(5 more ... CTD PMID:34480604 cyclosporin A increases expression ISO SH3BP5 (Homo sapiens) 6480464 Cyclosporine results in increased expression of SH3BP5 mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO SH3BP5 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SH3BP5 mRNA CTD PMID:27989131 dexamethasone multiple interactions ISO SH3BP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SH3BP5 mRNA CTD PMID:28628672 diethyl maleate increases expression ISO SH3BP5 (Homo sapiens) 6480464 diethyl maleate results in increased expression of SH3BP5 mRNA CTD PMID:33545341 diethyl maleate affects expression ISO SH3BP5 (Homo sapiens) 6480464 diethyl maleate affects the expression of SH3BP5 mRNA CTD PMID:34480604 dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of SH3BP5 mRNA CTD PMID:20880076 dioxygen increases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Oxygen deficiency results in increased expression of SH3BP5 protein CTD PMID:28315715 disodium selenite increases expression ISO SH3BP5 (Homo sapiens) 6480464 Sodium Selenite results in increased expression of SH3BP5 mRNA CTD PMID:18175754 diuron decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Diuron results in decreased expression of SH3BP5 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO SH3BP5 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH3BP5 mRNA CTD PMID:27188386 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of SH3BP5 mRNA CTD PMID:35436446 ethanol affects expression EXP 6480464 Ethanol affects the expression of SH3BP5 mRNA CTD PMID:30319688 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of SH3BP5 mRNA CTD PMID:30319688 fipronil increases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 fipronil results in increased expression of SH3BP5 mRNA CTD PMID:23962444 flutamide decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Flutamide results in decreased expression of SH3BP5 mRNA CTD PMID:24136188 furan increases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 furan results in increased expression of SH3BP5 mRNA CTD PMID:26194646 glafenine decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Glafenine results in decreased expression of SH3BP5 mRNA CTD PMID:24136188 indometacin multiple interactions ISO SH3BP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SH3BP5 mRNA CTD PMID:28628672 L-ascorbic acid multiple interactions ISO SH3BP5 (Homo sapiens) 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SH3BP5 mRNA CTD PMID:34480604 L-ascorbic acid 2-phosphate multiple interactions ISO SH3BP5 (Homo sapiens) 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SH3BP5 mRNA CTD PMID:34480604 leflunomide increases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 leflunomide results in increased expression of SH3BP5 mRNA CTD PMID:24136188 levofloxacin increases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Levofloxacin results in increased expression of SH3BP5 mRNA CTD PMID:24136188 metformin decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Metformin results in decreased expression of SH3BP5 mRNA CTD PMID:31324951 methapyrilene decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Methapyrilene results in decreased expression of SH3BP5 mRNA CTD PMID:30467583 methapyrilene decreases methylation ISO SH3BP5 (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of SH3BP5 intron CTD PMID:30157460 methylseleninic acid affects expression ISO SH3BP5 (Homo sapiens) 6480464 methylselenic acid affects the expression of SH3BP5 mRNA CTD PMID:14617803 mitomycin C affects response to substance ISO SH3BP5 (Homo sapiens) 6480464 SH3BP5 protein affects the susceptibility to Mitomycin CTD PMID:16217747 N-Nitrosopyrrolidine increases expression ISO SH3BP5 (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in increased expression of SH3BP5 mRNA CTD PMID:32234424 oxaliplatin multiple interactions ISO Sh3bp5 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SH3BP5 mRNA CTD PMID:25729387 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SH3BP5 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SH3BP5 mRNA CTD PMID:34911549 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SH3BP5 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SH3BP5 mRNA] CTD PMID:17585979 paracetamol decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of SH3BP5 mRNA CTD PMID:30723492 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SH3BP5 protein CTD PMID:27773698 paracetamol increases expression ISO SH3BP5 (Homo sapiens) 6480464 Acetaminophen results in increased expression of SH3BP5 mRNA CTD PMID:21420995 more ... paracetamol decreases expression ISO SH3BP5 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SH3BP5 mRNA CTD PMID:27761495 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of SH3BP5 mRNA CTD PMID:17562736 perfluorohexanesulfonic acid increases expression EXP 6480464 perfluorohexanesulfonic acid results in increased expression of SH3BP5 mRNA CTD PMID:37995155 perfluorononanoic acid increases expression ISO SH3BP5 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in increased expression of SH3BP5 mRNA CTD PMID:32588087 phenobarbital affects expression ISO SH3BP5 (Homo sapiens) 6480464 Phenobarbital affects the expression of SH3BP5 mRNA CTD PMID:19159669 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of SH3BP5 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO SH3BP5 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of SH3BP5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO SH3BP5 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH3BP5 mRNA CTD PMID:27188386 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of SH3BP5 mRNA CTD PMID:21278054 resveratrol multiple interactions ISO SH3BP5 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of SH3BP5 mRNA CTD PMID:23557933 rotenone increases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Rotenone results in increased expression of SH3BP5 protein CTD PMID:28315715 SB 431542 multiple interactions ISO SH3BP5 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:34480604 senecionine decreases expression EXP 6480464 senecionine results in decreased expression of SH3BP5 protein CTD PMID:35357534 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of SH3BP5 mRNA CTD PMID:19073995 sodium arsenite decreases expression ISO SH3BP5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SH3BP5 mRNA CTD PMID:34032870 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of SH3BP5 mRNA CTD PMID:37682722 tauroursodeoxycholic acid decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 ursodoxicoltaurine results in decreased expression of SH3BP5 mRNA CTD PMID:15885361 Tesaglitazar decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 tesaglitazar results in decreased expression of SH3BP5 mRNA CTD PMID:21515302 tetrachloromethane multiple interactions ISO Sh3bp5 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SH3BP5 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SH3BP5 mRNA CTD PMID:31919559 tetrachloromethane decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of SH3BP5 mRNA CTD PMID:31150632 thioacetamide decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of SH3BP5 mRNA CTD PMID:23411599 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of SH3BP5 mRNA CTD PMID:27760801 and PMID:29264374 topotecan decreases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 Topotecan results in decreased expression of SH3BP5 mRNA CTD PMID:25729387 topotecan multiple interactions ISO Sh3bp5 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SH3BP5 mRNA CTD PMID:25729387 triptonide decreases expression EXP 6480464 triptonide results in decreased expression of SH3BP5 mRNA CTD PMID:33045310 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of SH3BP5 mRNA CTD PMID:28973697 trovafloxacin increases expression ISO Sh3bp5 (Rattus norvegicus) 6480464 trovafloxacin results in increased expression of SH3BP5 mRNA CTD PMID:24136188 urethane increases expression ISO SH3BP5 (Homo sapiens) 6480464 Urethane results in increased expression of SH3BP5 mRNA CTD PMID:28818685 valproic acid affects expression ISO SH3BP5 (Homo sapiens) 6480464 Valproic Acid affects the expression of SH3BP5 mRNA CTD PMID:25979313 valproic acid increases expression ISO SH3BP5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SH3BP5 mRNA CTD PMID:19101580 more ... XAV939 multiple interactions ISO SH3BP5 (Homo sapiens) 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SH3BP5 mRNA and [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SH3BP5 mRNA CTD PMID:34480604